Welcome to the Norwegian Experimental Cell Transplantation homepage
Hanne Scholz Group leader
The research group was established at the Institute of Surgical Research in 2005 and has focused on the development of new strategies to counteract the harmful effects of islet cells before transplantation, and to strengthen islet growth and function after transplantation.
Nordheim E, Jenssen TG, Lindahl JP, Fasting KL, Hugenschmidt H, Birkeland KI, Åsberg A, Midtvedt K, Scholz H, Boye TB, Heldal K, Hagness M(2026) Pankreastransplantasjon – fortsatt et godt behandlingsalternativ ved type 1-diabetes Tidsskr Nor Laegeforen, 146(3) DOI 10.4045/tidsskr.25.0794, PubMed 41778575
Josifovska N, Niemi EM, Ramalingam M, Manivasagam G, Scholz H, Petrovski G(2025) A pilot study for decellularizing porcine cornea for future use in corneal regeneration PLoS One, 20(12), e0339462 DOI 10.1371/journal.pone.0339462, PubMed 41474796
Carlsson PO, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, Eriksson O, Liss P, Yu D, Deuse T, Korsgren O, Schrepfer S(2025) Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression N Engl J Med, 393(9), 887-894 DOI 10.1056/NEJMoa2503822, PubMed 40757665